RCKT FY 2024 Earnings — Rocket Pharmaceuticals, Inc. Revenue & Financial Results | Market Cap Arena

RCKTRocket Pharmaceuticals, Inc.

$572M

FY 2024 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

$0

Operating Income

-$273M

Net Income

-$259M

EPS (Diluted)

$-2.73

Cash Flow

Operating Cash Flow

-$210M

Free Cash Flow

-$216M

Stock-Based Comp.

$44M

Balance Sheet

Total Assets

$528M

Total Liabilities

$64M

Stockholders' Equity

$463M

Cash & Equivalents

$164M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	$0	$0	—
Operating Income	-$273M	-$260M	-5.2%
Net Income	-$259M	-$246M	-5.4%